These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2517455)

  • 1. [Plasminogen activators in tumor tissue].
    Tomasiuk R; Mirowski M; Wierzbicki R
    Pol Arch Med Wewn; 1989 Jun; 81(6):355-63. PubMed ID: 2517455
    [No Abstract]   [Full Text] [Related]  

  • 2. Pro-urokinase: physiochemical properties and promotion of its fibrinolytic activity by urokinase and by tissue plasminogen activator with which it has a complementary mechanism of action.
    Gurewich V
    Semin Thromb Hemost; 1988 Jan; 14(1):110-5. PubMed ID: 3127884
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advances in fibrinolysis mediated by vascular endothelial cells].
    Zhou QS
    Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):318-22. PubMed ID: 2129251
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of plasminogen activators.
    Robbins KC; Barlow GH; Nguyen G; Samama MM
    Semin Thromb Hemost; 1987 Apr; 13(2):131-8. PubMed ID: 3114881
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 6. Human plasminogen activators. Genes and proteins structure.
    Blasi F; Riccio A; Sebastio G
    Horiz Biochem Biophys; 1986; 8():377-414. PubMed ID: 3093360
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiological consequences of loss of plasminogen activator gene function in mice.
    Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
    Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activators and cancer.
    Duffy MJ
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):681-7. PubMed ID: 2133247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of urokinase and its inhibitors in the invasiveness and metastasing of malignant tumors].
    Halámková J; Kiss I; Tomášek J; Pavlovský Z; Tuček S; Penka M
    Vnitr Lek; 2012 Feb; 58(2):129-34. PubMed ID: 22463093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of plasminogen activators in cancer dissemination. Clinical perspectives].
    Alonso DF; Bal de Kier Joffé E
    Medicina (B Aires); 1992; 52(3):252-6. PubMed ID: 1342692
    [No Abstract]   [Full Text] [Related]  

  • 12. Human seminal fibrinolytic activity: specific determinations of tissue plasminogen activator and urokinase.
    Van Dreden P; Gonzalès J; Poirot C
    Andrologia; 1991; 23(1):29-33. PubMed ID: 1910268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasminogen activator system and cancer.
    McMahon B; Kwaan HC
    Pathophysiol Haemost Thromb; 2008; 36(3-4):184-94. PubMed ID: 19176991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the fibrinolytic system in corneal angiogenesis.
    Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
    Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.
    Karlan BY; Clark AS; Littlefield BA
    Biochem Biophys Res Commun; 1987 Jan; 142(1):147-54. PubMed ID: 3101684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasminogen activators and their physiological role].
    Andreenko GV
    Ukr Biokhim Zh (1978); 1983; 55(3):329-43. PubMed ID: 6346623
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of single chain pro-UK on the initiation and regulation of fibrinolysis].
    Arimura H; Kasai S; Nishida M; Suyama T
    Rinsho Byori; 1989 Apr; Spec No 81():107-17. PubMed ID: 2502639
    [No Abstract]   [Full Text] [Related]  

  • 19. Human primary colon carcinomas xenografted into nude mice. I. Characterization of plasminogen activators expressed by primary tumors and their xenografts.
    Cajot JF; Sordat B; Kruithof EK; Bachmann F
    J Natl Cancer Inst; 1986 Sep; 77(3):703-12. PubMed ID: 3091899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activation and regulation of pericellular proteolysis.
    Saksela O
    Biochim Biophys Acta; 1985 Nov; 823(1):35-65. PubMed ID: 2413894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.